MCT1 exhibits widespread expression throughout the body [15], while MCT4 is predominantly found in highly glycolytic tissues [16,17,18], and their silencing has been shown to reduce tumor growth in different xenografts models of cancer [19,20,21,22,23]. The gene discussed is SLC16A1; the disease is cancer.